Segment Information (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
Segment Reporting [Abstract] |
|
Schedule of Reportable Business Segment Information |
Reportable business segment information is as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Net sales: |
|
|
|
|
|
|
|
Asia |
$ |
49,984 |
|
|
$ |
54,875 |
|
|
$ |
96,204 |
|
|
$ |
101,220 |
|
Europe |
21,602 |
|
|
21,236 |
|
|
43,898 |
|
|
42,641 |
|
North America |
33,563 |
|
|
34,658 |
|
|
70,088 |
|
|
69,306 |
|
Latin America and Other |
5,402 |
|
|
5,779 |
|
|
11,354 |
|
|
12,015 |
|
Total net sales |
110,551 |
|
|
116,548 |
|
|
221,544 |
|
|
225,182 |
|
|
|
|
|
|
|
|
|
Contribution margin (1): |
|
|
|
|
|
|
|
Asia |
23,557 |
|
|
26,899 |
|
|
45,213 |
|
|
48,850 |
|
Europe |
6,458 |
|
|
6,130 |
|
|
14,500 |
|
|
12,666 |
|
North America |
12,298 |
|
|
13,902 |
|
|
25,900 |
|
|
26,763 |
|
Latin America and Other |
1,881 |
|
|
2,379 |
|
|
3,989 |
|
|
4,845 |
|
Total contribution margin |
44,194 |
|
|
49,310 |
|
|
89,602 |
|
|
93,124 |
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses (2) |
38,557 |
|
|
42,273 |
|
|
79,341 |
|
|
85,915 |
|
Operating income |
5,637 |
|
|
7,037 |
|
|
10,261 |
|
|
7,209 |
|
|
|
|
|
|
|
|
|
Other income (loss), net |
(1,214) |
|
|
(1,087) |
|
|
(1,183) |
|
|
427 |
|
Income before provision for income taxes |
$ |
4,423 |
|
|
$ |
5,950 |
|
|
$ |
9,078 |
|
|
$ |
7,636 |
|
_________________________________________
(1) Contribution margin consists of net sales less cost of sales and volume incentives expense. (2) Service fees in China totaled $3.8 million and $6.9 million for the three and six-month periods ended June 30, 2024, respectively, compared to $5.2 million and $8.9 million for the three and six-month periods ended June 30, 2023. These service fees are included in selling, general and administrative expenses.
|
Schedule of Consolidated Net Sales Revenue by Geographical Locations |
From an individual country/region perspective, the United States, Taiwan and South Korea comprise 10 percent or more of consolidated net sales for the three and six-month periods ended June 30, 2024 and 2023, as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Net sales: |
|
|
|
|
|
|
|
United States |
$ |
30,948 |
|
|
$ |
32,088 |
|
|
$ |
64,636 |
|
|
$ |
64,074 |
|
Taiwan |
16,308 |
|
|
16,041 |
|
|
32,100 |
|
|
30,216 |
|
South Korea |
13,449 |
|
|
13,832 |
|
|
25,070 |
|
|
25,072 |
|
Other |
49,846 |
|
|
54,587 |
|
|
99,738 |
|
|
105,820 |
|
|
$ |
110,551 |
|
|
$ |
116,548 |
|
|
$ |
221,544 |
|
|
$ |
225,182 |
|
|
Revenue from External Customers by Products and Services |
Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Asia |
|
|
|
|
|
|
|
General health |
$ |
19,131 |
|
|
$ |
18,158 |
|
|
$ |
35,125 |
|
|
$ |
31,922 |
|
Immune |
2,249 |
|
|
1,312 |
|
|
3,933 |
|
|
1,774 |
|
Cardiovascular |
13,625 |
|
|
14,840 |
|
|
27,599 |
|
|
29,735 |
|
Digestive |
7,707 |
|
|
11,564 |
|
|
16,296 |
|
|
20,986 |
|
Personal care |
1,044 |
|
|
1,442 |
|
|
2,336 |
|
|
2,783 |
|
Weight management |
6,228 |
|
|
7,559 |
|
|
10,915 |
|
|
14,020 |
|
|
49,984 |
|
|
54,875 |
|
|
96,204 |
|
|
101,220 |
|
Europe |
|
|
|
|
|
|
|
General health |
$ |
9,534 |
|
|
$ |
8,615 |
|
|
$ |
19,336 |
|
|
$ |
17,789 |
|
Immune |
2,203 |
|
|
2,141 |
|
|
4,538 |
|
|
4,425 |
|
Cardiovascular |
2,296 |
|
|
2,302 |
|
|
4,715 |
|
|
4,821 |
|
Digestive |
5,947 |
|
|
6,331 |
|
|
11,860 |
|
|
12,069 |
|
Personal care |
1,145 |
|
|
1,254 |
|
|
2,413 |
|
|
2,431 |
|
Weight management |
477 |
|
|
593 |
|
|
1,036 |
|
|
1,106 |
|
|
21,602 |
|
|
21,236 |
|
|
43,898 |
|
|
42,641 |
|
North America |
|
|
|
|
|
|
|
General health |
$ |
15,032 |
|
|
$ |
15,857 |
|
|
$ |
31,439 |
|
|
$ |
31,390 |
|
Immune |
3,540 |
|
|
3,732 |
|
|
7,985 |
|
|
8,053 |
|
Cardiovascular |
3,757 |
|
|
3,761 |
|
|
7,741 |
|
|
7,349 |
|
Digestive |
8,555 |
|
|
8,761 |
|
|
17,723 |
|
|
17,492 |
|
Personal care |
1,581 |
|
|
1,634 |
|
|
3,153 |
|
|
3,098 |
|
Weight management |
1,098 |
|
|
913 |
|
|
2,047 |
|
|
1,924 |
|
|
33,563 |
|
|
34,658 |
|
|
70,088 |
|
|
69,306 |
|
Latin America and Other |
|
|
|
|
|
|
|
General health |
$ |
1,564 |
|
|
$ |
1,600 |
|
|
$ |
3,134 |
|
|
$ |
3,237 |
|
Immune |
594 |
|
|
668 |
|
|
1,317 |
|
|
1,412 |
|
Cardiovascular |
401 |
|
|
433 |
|
|
883 |
|
|
899 |
|
Digestive |
2,488 |
|
|
2,585 |
|
|
5,237 |
|
|
5,470 |
|
Personal care |
270 |
|
|
341 |
|
|
545 |
|
|
692 |
|
Weight management |
85 |
|
|
152 |
|
|
238 |
|
|
305 |
|
|
5,402 |
|
|
5,779 |
|
|
11,354 |
|
|
12,015 |
|
|
$ |
110,551 |
|
|
$ |
116,548 |
|
|
$ |
221,544 |
|
|
$ |
225,182 |
|
|
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country |
From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2024 |
|
December 31, 2023 |
Property, plant and equipment: |
|
|
|
United States |
$ |
39,569 |
|
|
$ |
41,239 |
|
Other |
5,263 |
|
|
3,761 |
|
Total property, plant and equipment, net |
$ |
44,832 |
|
|
$ |
45,000 |
|
|
Schedule of Segment Reporting Information |
Total assets per segment is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2024 |
|
December 31, 2023 |
Assets: |
|
|
|
Asia |
$ |
98,164 |
|
|
$ |
105,636 |
|
Europe |
18,468 |
|
|
20,920 |
|
North America |
112,667 |
|
|
116,052 |
|
Latin America and Other |
6,532 |
|
|
7,165 |
|
Total assets |
$ |
235,831 |
|
|
$ |
249,773 |
|
|